GridAI Technologies GRDX
NASDAQ GRDX
$3.57 -0.18 (-4.83%)
As of: Aug 21, 2026 · 3:59 PM EDT

GridAI Technologies (GRDX) Cash & Current Investments (2015 - 2025)

GridAI Technologies' (GRDX) quarterly Cash & Current Investments came in at $899784.0 in Q4 2025, up 450.41% YoY from $163476.0 in Q4 2024, and down 64.25% on a QoQ basis from $2.5 million in Q3 2025.

GridAI Technologies (GRDX) Cash & Current Investments (2015 - 2025) Analysis & Trends

GridAI Technologies (GRDX) has 11 years of Cash & Current Investments data on file, last reported at $899784.0 in Q4 2025.

  • Quarterly Cash & Current Investments rose 450.41% year-over-year to $899784.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $899784.0 (up 450.41% YoY) and the FY2025 annual result came in at $899784.0, up 450.41% from the prior year.
  • Cash & Current Investments eased to $899784.0 in Q4 2025, from $2.5 million in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $12.0 million in Q1 2021 to a low of $8948.0 in Q2 2025.
  • A 5-year average of $3.2 million and a median of $1.9 million in 2022 frame the typical range for Cash & Current Investments.
  • Annual changes were most pronounced in 2021 — Cash & Current Investments jumped 719.79% — and 2025, when it sank 98.73%.
  • Tracing GRDX's Cash & Current Investments over 5 years: stood at $8.2 million in 2021, then tumbled by 82.97% to $1.4 million in 2022, then surged by 167.39% to $3.8 million in 2023, then plunged by 95.65% to $163476.0 in 2024, then jumped by 450.41% to $899784.0 in 2025.
  • The last three Cash & Current Investments figures came in at $899784.0 (Q4 2025), $2.5 million (Q3 2025), and $8948.0 (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 7.85 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 7.99 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 5.18 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 5.14 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 5.10 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 3.31 Bn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 18.39 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 1.16 Bn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 836.99 Mn
10 GridAI Technologies 5.82 Mn 5.82 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 899,784.00
Sep 30, 2025 2.52 Mn
Jun 30, 2025 8,948.00
Mar 31, 2025 73,000.00
Dec 31, 2024 163,476.00
Sep 30, 2024 408,308.00
Jun 30, 2024 703,995.00
Mar 31, 2024 3.47 Mn
Dec 31, 2023 3.76 Mn
Sep 30, 2023 3.33 Mn
Jun 30, 2023 1.28 Mn
Mar 31, 2023 2.11 Mn
Dec 31, 2022 1.40 Mn
Sep 30, 2022 1.70 Mn
Jun 30, 2022 1.16 Mn
Mar 31, 2022 5.69 Mn
Dec 31, 2021 8.25 Mn
Sep 30, 2021 7.21 Mn
Jun 30, 2021 8.07 Mn
Mar 31, 2021 12.03 Mn